Mucha-Habermann disease following estrogen-progesterone therapy.
D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects; D009640:Norethindrone / Q000009:adverse effects; D010267:Parapsoriasis / Q000139:chemically induced*; D011372:Progestins / Q000009:adverse effects*; D013577:Syndrome; D014652:Vascular Diseases / Q000139:chemically induced
D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins; D008525:Medroxyprogesterone; D009640:Norethindrone